News | October 07, 2023
Emmes acquires VaxTRIALS
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Advances clinical research capabilities with leading regulatory grade registries platform
The launch of HULIO in the United States is an important milestone for Biocon Biologics
The drug discovery of mRNA-targeted small molecules is rapidly gaining attention due to the current difficulty of developing drugs against conventional protein targets
Subscribe To Our Newsletter & Stay Updated
